Bouziotis, P., Gourni, E., Xanthopoulos, S., Paravatou, M., Syrigos, K., Loudos, G., . . . Harris, A. (2008). Kit formulation of Bevacizumab, an anti-VEGF monoclonal antibody, and consequent labelling with Rhenium-188: Initial in vitro and in vivo studies.
Citación estilo ChicagoBouziotis, P., E. Gourni, S. Xanthopoulos, M. Paravatou, K. Syrigos, G. Loudos, S. Archimandritis, A. Varvarigou, and A. Harris. Kit Formulation of Bevacizumab, an Anti-VEGF Monoclonal Antibody, and Consequent Labelling with Rhenium-188: Initial in Vitro and in Vivo Studies. 2008.
Cita MLABouziotis, P., et al. Kit Formulation of Bevacizumab, an Anti-VEGF Monoclonal Antibody, and Consequent Labelling with Rhenium-188: Initial in Vitro and in Vivo Studies. 2008.
Warning: These citations may not always be 100% accurate.